Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Proks

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The Journal of General Physiology|September 30, 2010
Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1Peter Proks, Heidi de Wet, Frances M Ashcroft
EMBO Reports|January 14, 2003
The ligand-sensitive gate of a potassium channel lies close to the selectivity filterPeter Proks, Jennifer F Antcliff, Frances M Ashcroft
Diabetes|July 10, 2013
Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetesPeter Proks, Heidi de Wet, Frances M Ashcroft
Plos One|May 18, 2018
Binding of sulphonylureas to plasma proteins - A KATP channel perspectivePeter Proks, Holger Kramer, Elizabeth Haythorne, et al.
European Journal of Pharmacology|September 27, 2002
Inhibition of recombinant K(ATP) channels by the antidiabetic agents midaglizole, LY397364 and LY389382Peter Proks, Iris Treinies, Hans-Jürgen Mest, et al.
Diabetes|December 12, 2002
Sulfonylurea stimulation of insulin secretionPeter Proks, Frank Reimann, Nick Green, et al.
British Journal of Pharmacology|November 10, 2004
Inhibition of ATP-sensitive potassium channels by haloperidolShi-Bing Yang, Peter Proks, Frances M Ashcroft, et al.
The Journal of Physiology|September 5, 2018
Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K<sub>ATP</sub> channels by MgADP and metabolismNatascia Vedovato, Olof Rorsman, Konstantin Hennis, et al.
Biophysical Journal|April 2, 2003
Filter flexibility in a mammalian K channel: models and simulations of Kir6.2 mutantsCharlotte E Capener, Peter Proks, Frances M Ashcroft, et al.
Diabetes|May 30, 2006
Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapyPeter Proks, Christophe Girard, Halvor Baevre, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Journal of General Physiology|September 30, 2010
Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1Peter Proks, Heidi de Wet, Frances M Ashcroft
EMBO Reports|January 14, 2003
The ligand-sensitive gate of a potassium channel lies close to the selectivity filterPeter Proks, Jennifer F Antcliff, Frances M Ashcroft
Diabetes|July 10, 2013
Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetesPeter Proks, Heidi de Wet, Frances M Ashcroft
Plos One|May 18, 2018
Binding of sulphonylureas to plasma proteins - A KATP channel perspectivePeter Proks, Holger Kramer, Elizabeth Haythorne, et al.
European Journal of Pharmacology|September 27, 2002
Inhibition of recombinant K(ATP) channels by the antidiabetic agents midaglizole, LY397364 and LY389382Peter Proks, Iris Treinies, Hans-Jürgen Mest, et al.
Diabetes|December 12, 2002
Sulfonylurea stimulation of insulin secretionPeter Proks, Frank Reimann, Nick Green, et al.
British Journal of Pharmacology|November 10, 2004
Inhibition of ATP-sensitive potassium channels by haloperidolShi-Bing Yang, Peter Proks, Frances M Ashcroft, et al.
The Journal of Physiology|September 5, 2018
Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K<sub>ATP</sub> channels by MgADP and metabolismNatascia Vedovato, Olof Rorsman, Konstantin Hennis, et al.
Biophysical Journal|April 2, 2003
Filter flexibility in a mammalian K channel: models and simulations of Kir6.2 mutantsCharlotte E Capener, Peter Proks, Frances M Ashcroft, et al.
Diabetes|May 30, 2006
Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapyPeter Proks, Christophe Girard, Halvor Baevre, et al.
Pageof 6